KYTX: Kyverna Therapeutics, Inc. Stock

by  •  • Comments Off on KYTX: Kyverna Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 79.08
Enterprise Value ($M) -17.54
Book Value ($M) 266.59
Book Value / Share 6.17
Price / Book 0.30
NCAV ($M) 252.54
NCAV / Share 5.84
Price / NCAV 0.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.46
Return on Assets (ROA) -0.33
Return on Equity (ROE) -0.35

Liquidity (mrq)
Quick Ratio 8.61
Current Ratio 8.61

Balance Sheet (mrq) ($M)
Current Assets 290.60
Assets 304.64
Liabilities 38.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -142.60
Net Income -127.48

Cash Flow Statement (mra) ($M)
Cash From Operations -114.25
Cash from Investing -160.90
Cash from Financing 337.11

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G Westlake BioPartners Fund I, L.P. 10.50
10-10 13G Jpmorgan Chase & Co 5.50
05-03 13D Vida Ventures, LLC 11.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 41,869 274,069 15.28
2025-04-16 41,551 214,683 19.35
2025-04-15 51,228 183,489 27.92
2025-04-14 86,297 272,024 31.72

(click for more detail)

Similar Companies
KRON – Kronos Bio, Inc. KRYS – Krystal Biotech, Inc.
KURA – Kura Oncology, Inc. LVTX – LAVA Therapeutics N.V.
LXRX – Lexicon Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io